ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 668

Markers of Nitric Oxide and Hydroxyl Radical Formation Are Increased in Proliferative Lupus Nephritis and May Emanate From Increased Nitric Oxide Synthase and NADPH Oxidase Production and Reduced Endothelial Nitric Oxide Synthase-Derived NO Scavenging

Jim Oates1, Ahmad Mashmoushi1, Thomas Fleury1, Ann Hofbauer1 and Gary S. Gilkeson2, 1Medicine, Medical University of South Carolina, Charleston, SC, 2Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Biomarkers, Lupus nephritis, reactions and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The role of redox regulation of cell function in the different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes of lupus nephritis (LN) is not known. Different reactive intermediate (RI) species lead to differential changes in proteins that are important in transcriptional regulation and signaling. RIs are unstable species that can be measured indirectly by their ability to modify protein tyrosines (Tyr) and phenyalanines to form nitroTyr (NTyr, via peroxynitrite), metaTyr (mTyr, via hydroxyl radicals (OH·), usually metabolized from SO and H2O2), and chloroTyr (ClTyr, via HOCl). This study was designed to address the hypothesis that different classes of LN have distinct profiles of RI production.

Methods: 62 patients with active LN had a renal biopsy with ISN/RPS classification at screening. Serum and urine samples were collected before induction therapy for active LN. Serum (n=62) was analyzed for nitrate and nitrite (NOX, a marker of nitric oxide (NO) production) by chemiluminescence analyzer.  In a random subset of patients (n=34), serum proteins were analyzed for NTyr, mTyr, and ClTyr by HPLC with electrochemical detection and reported as the ratio of modified to unmodified Tyr * 1000. Snap frozen murine renal cortical tissue lysates from MRL/lpr and MRL/lpr NOS3 -/- (endothelial NO synthase or eNOS) mice with active proliferative LN were analyzed for superoxide (SO) production by luciginen assay with and without inhibitors of NOS and NADPH oxidase. Results were normalized to untreated MRL/lpr wildtype control tissue. Groups were compared by Wilcoxen rank sum or Student t test, and p < 0.05 was significant.

Results: Those with class IV LN had significantly higher levels of serum NOX. mTyr was elevated in those with class III and IV LN. In class V LN, NTyr and ClTyr were increased (differences not significant). SO production was increased (to 160%) in MRL/lpr NOS3-/- kidney cortex. This increase was reduced by both L-NMMA (a nonspecific NO synthase inhibitor, 70% of control) and DPI (a nonspecific NADPH oxidase inhibitor, 40% of control).

Levels of markers of RI production in patients with LN by ISN/RPS class

ISN/RPS Class

nitrate + nitrite

mTyr/Tyr*1000

ClTyr/Tyr*1000

Ntyr/Tyr*1000

Pure I

39 (n = 1)

0.6 (n = 1)

0.1 (n = 1)

0.2 (n = 1)

Pure II

30.2 ± 7.2 (n = 9)

0.2 ± 0.1 (n = 4)

0.1 ± 0 (n = 4)

0.3 ± 0.1 (n = 4)

Pure and mixed III

30.4 ± 5.3 (n = 29)

9 ± 5.5 (n = 17)

0.1 ± 0 (n = 18)

0.7 ± 0.3 (n = 18)

Pure and mixed IV

59.6 ± 17.8 (n = 12)

7.8 ± 4.2 (n = 8)

0.6 ± 0.3 (n = 9)

1.1 ± 0.3 (n = 9)

Pure V

24.9 ± 6.3 (n = 10)

0.7 ± 0.4 (n = 4)

13.9 ± 13.7 (n = 5)

21.2 ± 21 (n = 5)

Values reported as means ± standard error. Bolded values are significantly different from other classes.

 Conclusion: These results suggest increased NOS activity in class IV LN. In those with proliferative LN, increased OH• production or reduced antioxidant scavenging appears to be occurring. OH• can indirectly come from NADPH oxidase and NO synthase. Higher levels of SO in MRL/lpr cortical tissue from NOS3 -/- mice suggests that eNOS-derived NO can scavenge SO. Reduction of SO with both a NOS inhibitor and an NADPH oxidase inhibitor suggests that both enzymes produce SO, perhaps in a synergistic fashion, in proliferative LN. Therefore, effective therapy for SO-mediated redox signaling in proliferative LN may need to induce increases in the scavenging effect of eNOS-derived NO or target SO directly with scavengers. Myeloperoxidase (forms NTyr and ClTyr) may be an important enzyme target in class V disease.


Disclosure:

J. Oates,
None;

A. Mashmoushi,
None;

T. Fleury,
None;

A. Hofbauer,
None;

G. S. Gilkeson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/markers-of-nitric-oxide-and-hydroxyl-radical-formation-are-increased-in-proliferative-lupus-nephritis-and-may-emanate-from-increased-nitric-oxide-synthase-and-nadph-oxidase-production-and-reduced-endo/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology